Literature DB >> 11689621

Identification of the rhesus macaque rhadinovirus lytic origin of DNA replication.

G S Pari1, D AuCoin, K Colletti, S A Cei, V Kirchoff, S W Wong.   

Abstract

We have identified a lytic origin of DNA replication (oriLyt) for rhesus macaque rhadinovirus (RRV), the rhesus macaque homolog of human herpesvirus 8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus. RRV oriLyt maps to the region of the genome between open reading frame 69 (ORF69) and ORF71 (vFLIP) and is composed of an upstream A+T-rich region followed by a short (300-bp) downstream G+C-rich DNA sequence. A set of overlapping cosmids corresponding to the entire genome of RRV was capable of complementing oriLyt-dependent DNA replication only when additional ORF50 was supplied as an expression plasmid in the transfection mixture, suggesting that the level of ORF50 protein originating from input cosmid DNA was insufficient. The requirement of RRV ORF50 in the cotransfection replication assay may also suggest a direct role for this protein in DNA replication. RRV oriLyt shares a high degree of nucleotide sequence and G+C base distribution with the corresponding loci in HHV-8.

Entities:  

Mesh:

Year:  2001        PMID: 11689621      PMCID: PMC114726          DOI: 10.1128/JVI.75.23.11401-11407.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Telomerase catalytic subunit homologs from fission yeast and human.

Authors:  T M Nakamura; G B Morin; K B Chapman; S L Weinrich; W H Andrews; J Lingner; C B Harley; T R Cech
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

2.  Extension of life-span by introduction of telomerase into normal human cells.

Authors:  A G Bodnar; M Ouellette; M Frolkis; S E Holt; C P Chiu; G B Morin; C B Harley; J W Shay; S Lichtsteiner; W E Wright
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

3.  Kaposi's sarcoma and the new herpesvirus.

Authors:  H D Birley; T F Schultz
Journal:  J Med Microbiol       Date:  1997-06       Impact factor: 2.472

4.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells.

Authors:  G Miller; L Heston; E Grogan; L Gradoville; M Rigsby; R Sun; D Shedd; V M Kushnaryov; S Grossberg; Y Chang
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

6.  Sequence and genomic analysis of a Rhesus macaque rhadinovirus with similarity to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8.

Authors:  R P Searles; E P Bergquam; M K Axthelm; S W Wong
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

7.  Novel organizational features, captured cellular genes, and strain variability within the genome of KSHV/HHV8.

Authors:  J Nicholas; J C Zong; D J Alcendor; D M Ciufo; L J Poole; R T Sarisky; C J Chiou; X Zhang; X Wan; H G Guo; M S Reitz; G S Hayward
Journal:  J Natl Cancer Inst Monogr       Date:  1998

8.  Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression.

Authors:  R Sun; S F Lin; K Staskus; L Gradoville; E Grogan; A Haase; G Miller
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein.

Authors:  D M Lukac; R Renne; J R Kirshner; D Ganem
Journal:  Virology       Date:  1998-12-20       Impact factor: 3.616

10.  Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection.

Authors:  G Miller; M O Rigsby; L Heston; E Grogan; R Sun; C Metroka; J A Levy; S J Gao; Y Chang; P Moore
Journal:  N Engl J Med       Date:  1996-05-16       Impact factor: 91.245

View more
  7 in total

1.  Evaluation of the lytic origins of replication of Kaposi's sarcoma-associated virus/human herpesvirus 8 in the context of the viral genome.

Authors:  Yiyang Xu; Alicia Rodriguez-Huete; Gregory S Pari
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Kaposi's sarcoma-associated herpesvirus lytic origin (ori-Lyt)-dependent DNA replication: identification of the ori-Lyt and association of K8 bZip protein with the origin.

Authors:  Cui Li Lin; Hong Li; Yan Wang; Fan Xiu Zhu; Sagar Kudchodkar; Yan Yuan
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  Identification and functional characterization of the left origin of lytic replication of murine gammaherpesvirus 68.

Authors:  Danyang Gong; Jing Qi; Vaithilingaraja Arumugaswami; Ren Sun; Hongyu Deng
Journal:  Virology       Date:  2009-03-12       Impact factor: 3.616

4.  Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains two functional lytic origins of DNA replication.

Authors:  David P AuCoin; Kelly S Colletti; Yiyang Xu; Sylvia A Cei; Gregory S Pari
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

5.  Identification of cis sequences required for lytic DNA replication and packaging of murine gammaherpesvirus 68.

Authors:  Hongyu Deng; Julia T Chu; No-Hee Park; Ren Sun
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  Complete genome sequence of Pig-tailed macaque rhadinovirus 2 and its evolutionary relationship with rhesus macaque rhadinovirus and human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus.

Authors:  A Gregory Bruce; Margaret E Thouless; Anthony S Haines; Mark J Pallen; Adam Grundhoff; Timothy M Rose
Journal:  J Virol       Date:  2015-01-21       Impact factor: 5.103

7.  Multiple Lytic Origins of Replication Are Required for Optimal Gammaherpesvirus Fitness In Vitro and In Vivo.

Authors:  Christine Sattler; Beatrix Steer; Heiko Adler
Journal:  PLoS Pathog       Date:  2016-03-23       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.